Notícias e Atividades da Atavistik Bio

Veja o organograma con seus 16 executivos principais

Biografias mais buscadas da Atavistik Bio

• Bryan Stuart, Chief Executive Officer and Director
• Jeff Goater, Director
• Shaq Vayda, Director

Recentes movimentos de executivos em Atavistik Bio

• Mohammad Hirmand, ingressou na Companhia como Director  (Notícia publicada em 26 de setembro de 2024).

Criar um alerta
para seguir os movimentos de executivos da Atavistik Bio.

Atavistik Bio possui 2.350 concorrentes concorrentes Astellas Gene Therapies (Estados Unidos), Eurofins (Luxemburgo) e Lonza (Suíça).

Popular M&A news in Biotecnologia

• Sirius Therapeutics acaba de anunciar uma arrecadação de fundos de 50 milhões de dólares. (publicado em 16 de junho de 2025).
• BioNTech has announced the acquisition of CureVac  (publicado em 12 de junho de 2025).
• SpliceBio acaba de anunciar uma arrecadação de fundos de 135 milhões de dólares. (publicado em 11 de junho de 2025).

Outros contatos sugeridos na indústria do Biotecnologia

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships da WIRB-Copernicus Group
• Jasbir Seehra - Chief Executive Officer and Chairman of the Board da Keros Therapeutics
• Deepika Verma - Associate Director of Data Science and Digitalization da Wheeler Bio

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Atavistik Bio

• Atavistik Bio Announces Research Collaboration with Pfizer to Accelerate Discovery of Novel Precision Allosteric Therapeutics - Atavistik Bio
• Atavistik Bio Presents Preclinical Data on Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor, at EORTC-NCI-AACR Symposium - Atavistik Bio
• Atavistik Bio Announces Nomination of Precision Oncology Development Candidate, ATV-1601, a Selective Allosteric AKT1 E17K Small Molecule Inhibitor - Atavistik Bio
• Atavistik Bio Appoints Oncology Clinical Development Leader Mohammad Hirmand, M.D. to Board of Directors - Atavistik Bio
• Atavistik Bio Strengthens Leadership Team with Appointment of Paul Bruno, Ph.D. as Chief Business Officer - Atavistik Bio
• Atavistik Bio Raises Additional $40 Million to Advance Precision Allosteric Small Molecule Therapeutics - Atavistik Bio
• Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer - Atavistik Bio
• The Search to Unlock Protein-Metabolite Interactions: An interview with Jared Rutter, Ph.D. and Kevin Hicks, Ph.D. About Atavistik Bio’s Foundational Technology and the Inspiration - Atavistik Bio
• Atavistik Bio Announces Publication in Science by Co-Founder Jared Rutter Describing Foundational Technology for its Atavistik Metabolite-Protein Screening (AMPS) Platform - Atavistik Bio
• Atavistik Bio Announces Collaboration with Plex Research to Enrich the Informatics Capabilities of its AMPS Platform and Accelerate the Discovery of Novel Small Molecule Therapeutics - Atavistik Bio
• View more press releases Close

Redes sociais sobre Atavistik Bio

• Atavistik Bio na Wikipedia, Google News e Yahoo Finance
• Atavistik Bio na LinkedIn, Twitter e YouTube